Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Sticky patch could replace wires for hospital heart monitoring

NCT ID NCT07260721

Knowledge-focused Sponsor: Yonsei University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a small, sticky patch that records heart rhythms in hospitalized patients who need continuous monitoring. The patch sends data to a central system for real-time alerts and later review. Researchers want to see if it helps doctors make faster decisions about treatments like blood thinners or heart procedures. About 100 adults will wear the patch for up to 8 days.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
MEMO-Cue single-lead ECG patch telemetry system
What this could lead to
If successful, this could show that a simple, wearable patch is as good as or better than standard telemetry for catching heart rhythm problems in the hospital, potentially leading to faster treatment.
What could go wrong
This is a small, early study (100 people) at one hospital, without a comparison group. The patch may miss some arrhythmias or cause skin irritation, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 100 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Dec 2025

An estimate. Start dates often move.

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

19 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 19 years or older who provide written informed consent for participation. * Patients requiring in-hospital telemetry electrocardiogram monitoring during hospitalization. Exclusion Criteria: * Known hypersensitivity or allergic reaction to adhesives or hydrogel. * Presence of skin wounds at the intended application site of the investigational device. * Implanted cardiac electronic devices such as pacemakers, ICDs, or other CIEDs * Current or past history of skin cancer, rash, dermatologic disorders, keloid formation, or skin injury. * Any condition judged by the investigator to increase risk or make participation inappropriate. * Cognitive impairment that precludes understanding of study information or voluntary consent.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Arrhythmias are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Arrhythmias, Cardiac atrial fibrillation Bradycardia cardiac rhythm disease Tachycardia, Supraventricular ventricular tachycardia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Arrhythmias Atrial fibrillation Bradycardia Hospitalization Patient monitoring Supraventricular tachycardia Telemetry Ventricular tachycardia

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Yonsei University College of Medicine

    Seoul, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.